These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26256909)

  • 1. The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007-2012).
    Tomlinson JE; Byrne E; Pusterla N; Magdesian KG; Hilton HG; McGorum B; Davis E; Schoster A; Arroyo L; Dunkel B; Carslake H; Boston RC; Johnson AL
    J Vet Intern Med; 2015; 29(5):1403-9. PubMed ID: 26256909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Fibrinous Pleural Effusion with Survival and Complications in Horses with Pleuropneumonia (2002-2012): 74 Cases.
    Tomlinson JE; Reef VB; Boston RC; Johnson AL
    J Vet Intern Med; 2015; 29(5):1410-7. PubMed ID: 26259510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination fibrinolytic therapy in the treatment of chronic septic pleuropneumonia in a Thoroughbred gelding.
    Rendle DI; Armstrong SK; Hughes KJ
    Aust Vet J; 2012 Sep; 90(9):358-62. PubMed ID: 22928684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of recombinant tissue plasminogen activator (rTPA) for treatment of fibrin in the anterior chamber of the horse.
    Pereira R; Bowen M; Rapezzano G; Redpath A; Pratt S; Hallowell G
    Vet Med Sci; 2024 Jul; 10(4):e1448. PubMed ID: 38818763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapleural fibrinolytic therapy in the management of septic pleuropneumonia in a horse.
    Hilton H; Pusterla N
    Vet Rec; 2009 May; 164(18):558-9. PubMed ID: 19411687
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
    Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
    Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of recombinant tissue plasminogen activator in severe post-operative fibrinous reaction after uneventful phacoemulsification - a case series and review.
    Ibramsah AB; Cheong AI; Wan Muda WN; Ibrahim M
    Rom J Ophthalmol; 2022; 66(1):27-31. PubMed ID: 35531461
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study.
    Thomas R; Piccolo F; Miller D; MacEachern PR; Chee AC; Huseini T; Yarmus L; Bhatnagar R; Lee HJ; Feller-Kopman D; Maskell NA; Tremblay A; Lee YCG
    Chest; 2015 Sep; 148(3):746-751. PubMed ID: 25742001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator.
    Richard G; Lerche RC; Knospe V; Zeumer H
    Ophthalmology; 1999 Apr; 106(4):768-73. PubMed ID: 10201601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleural effusion associated with acute and chronic pleuropneumonia and pleuritis secondary to thoracic wounds in horses: 43 cases (1982-1992).
    Collins MB; Hodgson DR; Hutchins DR
    J Am Vet Med Assoc; 1994 Dec; 205(12):1753-8. PubMed ID: 7744650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children.
    Wells RG; Havens PL
    Radiology; 2003 Aug; 228(2):370-8. PubMed ID: 12893898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
    Mayer WJ; Hakim I; Haritoglou C; Gandorfer A; Ulbig M; Kampik A; Wolf A
    Acta Ophthalmol; 2013 May; 91(3):274-8. PubMed ID: 21952010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
    Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
    Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance.
    Bamgbola OF; del Rio M; Kaskel FJ; Flynn JT
    Pediatr Nephrol; 2005 Jul; 20(7):989-93. PubMed ID: 15843999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist Impact on Ischemic Stroke Care in the Emergency Department.
    Gosser RA; Arndt RF; Schaafsma K; Dang CH
    J Emerg Med; 2016 Jan; 50(1):187-93. PubMed ID: 26412104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats?
    Haelewyn B; Risso JJ; Abraini JH
    J Cereb Blood Flow Metab; 2010 May; 30(5):900-3. PubMed ID: 20216551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns].
    Álvarez Z P; Verdugo L P; Carvajal K L; Múhlhausen M G; Ríos A P; Rodríguez V D
    Rev Chil Pediatr; 2015; 86(3):194-9. PubMed ID: 26235268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema.
    Thommi G; Nair CK; Aronow WS; Shehan C; Meyers P; McLeay M
    Am J Ther; 2007; 14(4):341-5. PubMed ID: 17667208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of blood pressure and blood glucose to treatment with recombinant tissue-type plasminogen activator in acute ischemic stroke: evidence from the virtual international stroke trials archive.
    Kerr DM; Fulton RL; Higgins P; Bath PM; Shuaib A; Lyden P; Lees KR;
    Stroke; 2012 Feb; 43(2):399-404. PubMed ID: 22075999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.